Original Research

Published on 09 Jun 2021

Nrf2 Down-Regulation by Camptothecin Favors Inhibiting Invasion, Metastasis and Angiogenesis in Hepatocellular Carcinoma

in Pharmacology of Anti-Cancer Drugs

Qian Liu
Shanshan Zhao
Fanguang Meng
Hankang Wang
Liwei Sun
Guijie Li
Feng Gao
Feng Chen

Frontiers in Oncology

doi 10.3389/fonc.2021.661157

4,449 views
18 citations

Original Research

Published on 08 Jun 2021

Functionalized Selenium Nanotherapeutics Synergizes With Zoledronic Acid to Suppress Prostate Cancer Cell Growth Through Induction of Mitochondria-Mediated Apoptosis and Cell Cycle S Phase Arrest

in Pharmacology of Anti-Cancer Drugs

Yulin An
Jianfu Zhao

Frontiers in Oncology

doi 10.3389/fonc.2021.685784

3,087 views
16 citations

Case Report

Published on 08 Jun 2021

Novel MRPS9-ALK Fusion Mutation in a Lung Adenocarcinoma Patient: A Case Report

in Pharmacology of Anti-Cancer Drugs

Huamiao Zhou
Binyue Xu
Jili Xu
Guomeng Zhu
Yong Guo

Frontiers in Oncology

doi 10.3389/fonc.2021.670907

2,807 views
4 citations

Original Research

Published on 03 Jun 2021

3,3’-Diindolylmethane Enhances Paclitaxel Sensitivity by Suppressing DNMT1-Mediated KLF4 Methylation in Breast Cancer

in Pharmacology of Anti-Cancer Drugs

Fenfen Xiang
Zhaowei Zhu
Mengzhe Zhang
Jie Wang
Zixi Chen
Xiaoxiao Li
Tao Zhang
Qing Gu
Rong Wu
Xiangdong Kang

Frontiers in Oncology

doi 10.3389/fonc.2021.627856

3,761 views
14 citations

Original Research

Published on 03 Jun 2021

Chrysin Induced Cell Apoptosis Through H19/let-7a/COPB2 Axis in Gastric Cancer Cells and Inhibited Tumor Growth

in Pharmacology of Anti-Cancer Drugs

Lin Chen
Qirong Li
Ziping Jiang
Chengshun Li
Haobo Hu
Tiedong Wang
Yan Gao
Dongxu Wang

Frontiers in Oncology

doi 10.3389/fonc.2021.651644

4,333 views
20 citations

Correction

Published on 02 Jun 2021

Corrigendum: Emodin Interferes With AKT1-Mediated DNA Damage and Decreases Resistance of Breast Cancer Cells to Doxorubicin

in Pharmacology of Anti-Cancer Drugs

Bo Li
Xin Zhao
Lei Zhang
Wen Cheng

Frontiers in Oncology

doi 10.3389/fonc.2021.687841

1,442 views
2 citations

Original Research

Published on 28 May 2021

QTMP, a Novel Thiourea Polymer, Causes DNA Damage to Exert Anticancer Activity and Overcome Multidrug Resistance in Colorectal Cancer Cells

in Pharmacology of Anti-Cancer Drugs

Zhaoshi Bai
Qing Zhou
Huayun Zhu
Xinyue Ye
Pingping Wu
Lingman Ma

Frontiers in Oncology

doi 10.3389/fonc.2021.667689

2,391 views
1 citation

Original Research

Published on 28 May 2021

Cost-Effectiveness of Lorlatinib as a First-Line Therapy for Untreated Advanced Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer

in Pharmacology of Anti-Cancer Drugs

SiNi Li
JianHe Li
LiuBao Peng
YaMin Li
XiaoMin Wan

Frontiers in Oncology

doi 10.3389/fonc.2021.684073

7,000 views
10 citations

Original Research

Published on 28 May 2021

The Efficacy and Safety of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Combined With Thymosin in Advanced Non-Small Cell Lung Cancer Patients Harboring Active Epidermal Growth Factor Receptor Mutations

in Pharmacology of Anti-Cancer Drugs

Yongdong Feng
Guangkuo Zhu
Song Lang
Ping Hao
Guanghui Li
Fanglin Chen
Wenlei Zhuo
Yuzhong Duan
Anmei Zhang
Zhengtang Chen

Frontiers in Oncology

doi 10.3389/fonc.2021.659065

2,334 views
6 citations

Review

Published on 28 May 2021

Combination Strategies to Augment Immune Check Point Inhibitors Efficacy - Implications for Translational Research

in Pharmacology of Anti-Cancer Drugs

Hrishi Varayathu
Vinu Sarathy
Beulah Elsa Thomas
Suhail Sayeed Mufti
Radheshyam Naik

Frontiers in Oncology

doi 10.3389/fonc.2021.559161

10,484 views
45 citations

Original Research

Published on 27 May 2021

Using Liposomes to Alleviate the Toxicity of Chelerythrine, a Natural PKC Inhibitor, in Treating Non-Small Cell Lung Cancer

in Pharmacology of Anti-Cancer Drugs

Jiahui Wang
Yijie Song
Ning Zhang
Ning Li
Congying Liu
Bing Wang

Frontiers in Oncology

doi 10.3389/fonc.2021.658543

2,876 views
7 citations

Review

Published on 26 May 2021

Breast Cancer Resistance to Cyclin-Dependent Kinases 4/6 Inhibitors: Intricacy of the Molecular Mechanisms

in Pharmacology of Anti-Cancer Drugs

Bin Wang
Rui Li
Shuai Wu
Xin Liu
Jianlin Ren
Jing Li
Kaixin Bi
Yanhong Wang
Hongyan Jia

Frontiers in Oncology

doi 10.3389/fonc.2021.651541

7,423 views
12 citations

Mini Review

Published on 25 May 2021

Vitamin D: Possible Therapeutic Roles in Hepatocellular Carcinoma

in Pharmacology of Anti-Cancer Drugs

Isaacson B. Adelani
Oluwakemi A. Rotimi
Emmanuel N. Maduagwu
Solomon O. Rotimi

Frontiers in Oncology

doi 10.3389/fonc.2021.642653

6,235 views
9 citations

Original Research

Published on 24 May 2021

Comparison of the Efficacy of S-1 Plus Oxaliplatin or Capecitabine Plus Oxaliplatin for Six and Eight Chemotherapy Cycles as Adjuvant Chemotherapy in Patients With Stage II-III Gastric Cancer After D2 Resection

in Pharmacology of Anti-Cancer Drugs

Yuanyuan Yu
Zicheng Zhang
Qianhao Meng
Yue Ma
Xiaona Fan
Jie Sun
Guangyu Wang

Frontiers in Oncology

doi 10.3389/fonc.2021.684627

2,603 views
2 citations

Original Research

Published on 24 May 2021

Targeting Mutated p53 Dependency in Triple-Negative Breast Cancer Cells Through CDK7 Inhibition

in Pharmacology of Anti-Cancer Drugs

Jingyu Peng
Ming Yang
Ran Bi
Yueyuan Wang
Chunxi Wang
Xue Wei
Zhihao Zhang
Xiao Xie
Wei Wei

Frontiers in Oncology

doi 10.3389/fonc.2021.664848

5,056 views
14 citations

Review

Published on 20 May 2021

Curcumin in Osteosarcoma Therapy: Combining With Immunotherapy, Chemotherapeutics, Bone Tissue Engineering Materials and Potential Synergism With Photodynamic Therapy

in Pharmacology of Anti-Cancer Drugs

Chunfeng Xu
Mingjie Wang
Wei Guo
Wei Sun
Yuelian Liu

Frontiers in Oncology

doi 10.3389/fonc.2021.672490

10,280 views
38 citations

Navigation group

Articles

Nrf2 Down-Regulation by Camptothecin Favors Inhibiting Invasion, Metastasis and Angiogenesis in Hepatocellular Carcinoma

Functionalized Selenium Nanotherapeutics Synergizes With Zoledronic Acid to Suppress Prostate Cancer Cell Growth Through Induction of Mitochondria-Mediated Apoptosis and Cell Cycle S Phase Arrest

Novel MRPS9-ALK Fusion Mutation in a Lung Adenocarcinoma Patient: A Case Report

3,3’-Diindolylmethane Enhances Paclitaxel Sensitivity by Suppressing DNMT1-Mediated KLF4 Methylation in Breast Cancer

Chrysin Induced Cell Apoptosis Through H19/let-7a/COPB2 Axis in Gastric Cancer Cells and Inhibited Tumor Growth

Corrigendum: Emodin Interferes With AKT1-Mediated DNA Damage and Decreases Resistance of Breast Cancer Cells to Doxorubicin

QTMP, a Novel Thiourea Polymer, Causes DNA Damage to Exert Anticancer Activity and Overcome Multidrug Resistance in Colorectal Cancer Cells

Cost-Effectiveness of Lorlatinib as a First-Line Therapy for Untreated Advanced Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer

The Efficacy and Safety of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Combined With Thymosin in Advanced Non-Small Cell Lung Cancer Patients Harboring Active Epidermal Growth Factor Receptor Mutations

Combination Strategies to Augment Immune Check Point Inhibitors Efficacy - Implications for Translational Research

Using Liposomes to Alleviate the Toxicity of Chelerythrine, a Natural PKC Inhibitor, in Treating Non-Small Cell Lung Cancer

Breast Cancer Resistance to Cyclin-Dependent Kinases 4/6 Inhibitors: Intricacy of the Molecular Mechanisms

Vitamin D: Possible Therapeutic Roles in Hepatocellular Carcinoma

Comparison of the Efficacy of S-1 Plus Oxaliplatin or Capecitabine Plus Oxaliplatin for Six and Eight Chemotherapy Cycles as Adjuvant Chemotherapy in Patients With Stage II-III Gastric Cancer After D2 Resection

Targeting Mutated p53 Dependency in Triple-Negative Breast Cancer Cells Through CDK7 Inhibition

Curcumin in Osteosarcoma Therapy: Combining With Immunotherapy, Chemotherapeutics, Bone Tissue Engineering Materials and Potential Synergism With Photodynamic Therapy